Heywood, Benjamin R., Morgan, Christopher Ll., Berni, Thomas R., Summers, Darren R., Jones, Bethan I., Jenkins-Jones, Sara, Holden, Sarah E., Riddick, Lauren D., Fisher, Harry, Bateman, James D., Bannister, Christian A. ![]() ![]() |
![]() |
Currie, Craig J., Holden, Sarah E., Jenkins-Jones, Sara, Morgan, Christopher Ll, Voss, Bernd, Rajpathak, Swapnil N., Alemayehu, Berhanu, Peters, John R. and Engel, Samuel S. 2018. Impact of differing glucose-lowering regimens on the pattern of association between glucose control and survival. Diabetes, Obesity and Metabolism 20 (4) , pp. 821-830. 10.1111/dom.13155 |
|
Holden, Sarah E., Jenkins-Jones, Sara and Currie, Craig J. 2016. Association between insulin monotherapy versus insulin plus metformin and the risk of all-cause mortality and other serious outcomes: a retrospective cohort study. PLoS ONE 11 (5) , e0153594. 10.1371/journal.pone.0153594 |
![]() |
Holden, Sarah E. 2016. Diabetes and cancer. Mullis, P.E., Stettler, C, Christ, E and Diem, P, eds. Novelties in Diabetes, Endocrine Development, vol. 31. Karger, pp. 135-145. |
![]() |
Holden, Sarah E.
2015.
A study of the descriptive epidemiology and clinical effectiveness of treatment for type 2 diabetes using routine general practice data.
PhD Thesis,
Cardiff University.
![]() Item availability restricted. |
![]() |
Holden, Sarah E., Jenkins-Jones, S., Morgan, Christopher L., Schernthaner, G. and Currie, Craig John 2014. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer. Diabetes, Obesity and Metabolism 17 (4) , pp. 350-362. 10.1111/dom.12412 |
![]() |
Bannister, Christian ![]() |
![]() |
Holden, Sarah and Currie, Craig 2014. Mortality risk with sulphonylureas compared to metformin. Diabetes, Obesity and Metabolism 16 (10) , pp. 885-890. 10.1111/dom.12280 |
![]() |
Currie, Craig and Holden, Sarah 2014. Optimizing clinical outcomes resulting from glucose-lowering therapies in type 2 diabetes: increased confidence about the DPP-4 inhibitors and continued concerns regarding sulphonylureas and exogenous insulin. Diabetes, Obesity and Metabolism 16 (10) , pp. 881-884. 10.1111/dom.12349 |
![]() |
Holden, Sarah, Gale, E.A.M., Jenkins-Jones, S. and Currie, Craig 2014. How many people inject insulin? UK estimates from 1991 to 2010. Diabetes, Obesity and Metabolism 16 (6) , pp. 553-559. 10.1111/dom.12260 |
![]() |
Holden, Sarah, Barnett, A.H., Peters, J.R., Jenkins-Jones, S., Poole, C.D., Morgan, Christopher and Currie, Craig 2013. The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes, Obesity and Metabolism 15 (9) , pp. 844-852. 10.1111/dom.12123 |
![]() |
Holden, Sarah E. 2012. Gluten-free foods and the cost of prescriptions [Letter]. Journal of Human Nutrition and Dietetics 25 (4) , p. 405. 10.1111/j.1365-277X.2012.01261.x |
![]() |
Poole, Christopher David, Currie, Craig John, Holden, Sarah E. and Singh, A. 2012. PMS19 Impact of disease severity on the total, health-related, financial costs of treatment of people with rheumatoid arthritis in the United Kingdom [Abstract]. Value In Health 15 (4) , A36-A37. 10.1016/j.jval.2012.03.208 |
![]() |
Holden, Sarah E. and Currie, Craig John 2012. Endogenous hyperinsulinaemia and exogenous insulin: a common theme between atherosclerosis, increased cancer risk and other morbidities. Atherosclerosis 222 (1) , pp. 26-28. 10.1016/j.atherosclerosis.2012.01.052 |
![]() |
Holden, Sarah E., Poole, Christopher David, Morgan, Christopher L. and Currie, Craig John 2011. Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin. British Medical Journal Open 1 (2) , e000258. 10.1136/bmjopen-2011-000258 |
|